Published in Clin Infect Dis on April 12, 2005
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2015) 4.07
Candida infections of the genitourinary tract. Clin Microbiol Rev (2010) 1.90
Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol (2007) 1.17
Invasive fungal infections in solid organ transplant recipients. Future Microbiol (2012) 1.01
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
A murine model for catheter-associated candiduria. J Med Microbiol (2011) 0.86
Fungal infections in renal transplant patients. J Clin Med Res (2015) 0.85
Candida nivariensis isolated from a renal transplant patient with persistent candiduria-Molecular identification using ITS PCR and MALDI-TOF. Med Mycol Case Rep (2013) 0.78
Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? Mycoses (2012) 0.78
Diagnosis and inflammatory response of patients with candiduria. Mycoses (2012) 0.78
Identification of Candida Species Isolated from Renal Transplant Recipients with Candiduria. Int J Organ Transplant Med (2016) 0.78
Urinary tract infection in renal transplantation. Arab J Urol (2012) 0.77
Association Between Candiduria and Candidemia: A Clinical and Molecular Analysis of Cases. Mycopathologia (2017) 0.75
Characterization and identification of candiduria due to Candida species in diabetic patients. Curr Med Mycol (2016) 0.75
Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol (2005) 5.12
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J (1996) 3.59
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat (2011) 3.40
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint. Antimicrob Agents Chemother (2001) 3.33
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol (2008) 2.95
Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med (1994) 2.93
Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89
Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother (2006) 2.89
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci (1998) 2.65
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat (2010) 2.59
In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (2000) 2.39
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98
Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med (2004) 1.87
Experience with reduced-size liver transplantation. Surg Gynecol Obstet (1990) 1.87
Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol (2005) 1.81
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis (2015) 1.61
Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med (2011) 1.56
Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging (2006) 1.56
Effects of dog ownership and genotype on immune development and atopy in infancy. J Allergy Clin Immunol (2004) 1.55
Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens (2004) 1.50
A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics (2005) 1.47
The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation (1991) 1.45
Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology (2009) 1.42
Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol (2006) 1.39
Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr (2005) 1.36
Pyramidal appearance and resistive index: insensitive and nonspecific sonographic indicators of renal transplant rejection. AJR Am J Roentgenol (1990) 1.36
Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol (2003) 1.35
Liver transplantation from controlled non-heart-beating donors. Surgery (2000) 1.32
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. Ann Surg (1993) 1.31
Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med (2003) 1.29
Comparison between duodenal button and duodenal segment in pancreas transplantation. Transplantation (1989) 1.21
Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med (1986) 1.18
Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol (2012) 1.17
Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg (2000) 1.16
Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg (1998) 1.16
Living related and unrelated donors for kidney transplantation. A 28-year experience. Ann Surg (1995) 1.15
Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery (1998) 1.13
Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo. Antimicrob Agents Chemother (1999) 1.11
Tertiary hyperparathyroidism after renal transplantation: operative indications. Surgery (1989) 1.11
Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery (1995) 1.07
OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. Transplant Proc (1991) 1.07
Latrunculin-A increases outflow facility in the monkey. Invest Ophthalmol Vis Sci (1999) 1.07
Experience with Belzer UW cold storage solution in human liver transplantation. Transplant Proc (1990) 1.06
Retransplantation of the liver--a seven-year experience. Transplantation (1993) 1.06
Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost (2008) 1.05
Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol (2001) 1.04
Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation (2000) 1.03
FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group. Transplant Proc (1997) 1.03
The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc (1991) 1.01
Urological complications and enteric conversion after pancreas transplantation with bladder drainage. Transplant Proc (1994) 1.00
Efficacy of micafungin for the treatment of candidemia. Eur J Clin Microbiol Infect Dis (2005) 1.00
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin Infect Dis (2005) 1.00
Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. Clin Exp Allergy (2013) 0.99
Combined cold storage-perfusion preservation with a new synthetic perfusate. Transplantation (1989) 0.99
Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrob Agents Chemother (2006) 0.98
Differential diagnosis of hyperamylasemia in pancreas allograft recipients. Transplant Proc (1990) 0.98
The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg (1992) 0.97
The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis. J Pediatr (2010) 0.97
Preliminary experience with split liver transplantation. J Am Coll Surg (1996) 0.97
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics (2009) 0.97
Viral infections, cytokine dysregulation and the origins of childhood asthma and allergic diseases. Pediatr Infect Dis J (2005) 0.96
Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. J Cyst Fibros (2005) 0.95
Liver transplantation in alcoholics: assessment of psychological health and work activity. Transplant Proc (1993) 0.95
Indications for enteric conversion after pancreas transplantation with bladder drainage. Surgery (1992) 0.95
Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy. Transplantation (1989) 0.94
Liver transplantation in infants and children. J Pediatr Surg (1989) 0.94
Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis (2009) 0.93
Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. Transplantation (1999) 0.93
Kidney retransplantation in the cyclosporine era. Transplantation (1988) 0.93
The influence of processing factors and non-atopy-related maternal and neonate characteristics on yield and cytokine responses of cord blood mononuclear cells. Clin Exp Allergy (2007) 0.93
Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression. Surgery (1987) 0.92
Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int (2000) 0.91
Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr (2003) 0.90
Peripheral vascular disease and renal transplant artery stenosis: a reappraisal of transplant renovascular disease. Clin Transplant (1999) 0.90
Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. HIV Med (2009) 0.90
Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant (2006) 0.89
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Transplantation (2000) 0.89
Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. Surgery (1993) 0.88
Use of UW solution in pancreas transplantation. Diabetes (1989) 0.88
The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation (1996) 0.88
Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation (1988) 0.88
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis. Pediatr Pulmonol (2011) 0.88
Liver transplantation for alcoholic liver disease. Surgery (1992) 0.87
Should abdominal cluster transplantation be abandoned? Transplant Proc (1993) 0.87
The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Transplant Proc (2008) 0.87
Changes in tobacco quitlines in the United States, 2005-2006. Prev Chronic Dis (2010) 0.86
A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. Am J Transplant (2008) 0.86
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation (1996) 0.86
Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes. Am J Transplant (2013) 0.85
Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc (2014) 0.85
Opportunities for quality improvement in cystic fibrosis newborn screening. J Cyst Fibros (2010) 0.85
100 consecutive liver transplants in infants and children: an 8-year experience. J Pediatr Surg (1994) 0.85
Experience with Belzer UW cold storage solution in simultaneous pancreas-kidney transplantation. Transplant Proc (1990) 0.85
Living unrelated kidney donation: an underutilized resource? Transplant Proc (1993) 0.85